the aid library

LIST OPTIONS

Filter

8461

Download (181)

View PDF (223)

Resource materials for in- country development and implementation of national action plans to address antimicrobial resistance

World Health Organization WHO (2021) C_WHO

Download (1051)

View PDF (1178)

The Future Is Inclusive – How to Make International Development Disability Inclusive

Mary Keogh, Monika Brenes, Priska Gronenberg et al. Christoffel Blinden Mission (CBM) (2014)

Series on Disability-Inclusive Development. This publication introduces the key concepts for disability-inclusive development and highlights practical examples by CBM, to contribute to the dialogue on disability-inclusive development

Download (335)

View PDF (529)

CONTINUING PROFESSIONAL DEVELOPMENT (CPD) POLICY FOR HEALTH PROFESSIONAL COUNCILS IN RWANDA

Rwanda Medical and Dental Council (RMDC), National Council for Nurses and Midwives (NCNM), National Pharmacy Council (NPC) and Rwanda Allied Health Professionals Council (RAHPC) (2013) C2

This CPD Policy relates to all health professionals in the four Health Professional Councils in Rwanda namely; RMDC, NCNM, RAHPC, and RPC. The policy requires all health professionals to participate in the CPD Programs. The purpose of this CPD Policy is to support the professionals in the respective... more

External Link

Smart and Sustainable Cities: The Main Guidelines of City Statute for Increasing the Intelligence of Brazilian Cities

E. G. Lima, Chinelli C. K., Azevedo Guedes A. L., et al. (2020) CC

Sustainability 2020, 12, 1025

Download (482)

View PDF (829)

Nepal: Vulnerable Community Development Plan. Nepali Version
recommended

Ministry of Health, Government of Nepal (2016) C1

Download (2410)

View PDF (2557)

Disability Inclusive Development Toolkit
recommended

Al Ju’beh K Christoffel Blinden Mission (CBM) (2015) CC

This toolkit is designed as a resource for CBM that can be used in a variety of ways: to support staff induction, team meetings, refresher days and training workshops. It can also be used as a tool for personal reflection and self-study. Tips for those intending to use it as a training resource are ... more

Download (182)

View PDF (227)

Financing for Sustainable Development Report 2020

Inter-agency Task Force on Financing for Development United Nations (UN) (2020) CC

The 2020 Financing for Sustainable Development Report, the fifth report of the Inter-agency Task Force on Financing for Development, provides a comprehensive assessment of the state of sustainable finance. Prepared by more than 60 agencies of the United Nations system and partner international organ... more

Download (546)

View PDF (724)

Nepal: Multi-Sectoral Nutrition Plan Implementation Guidelines

Government of Nepal National Planning Commission (2012) C1

Download (245)

View PDF (393)

European Drug Report 2019: trends and developments.

European Monitoring Centre for Drugs and Drug Addiction European Union (2019) C1

The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together with the online Statistical Bulletin and 30 Country Drug Reports, it makes up the 2019 European Drug ... more

Download (351)

View PDF (458)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

External Link

Integration of childhood TB into guidelines for the management of acute malnutrition in high burden countries

L. N. Patel,and A. K. Detjen The Union (2017) C2

Public Health Action PHA 2017; 7(2): 110–115

Download (246)

View PDF (339)

Addressing Poverty Through Disability Inclusive Development: 8 Partner Case Studies

Australian Aid & CBM Christoffel-Blindenmission (CBM) (2010)

This booklet shows what disability inclusive development for poverty alleviation looks like in a range of settings and with different challenges through eight case studies of projects funded by CBM Australia through the Australian Government NGO Cooperation Program (ANCP).

Download (3774)

View PDF (1227)

Health Sector Development Programme IV 2010/11 – 2014/15

Federal Democratic Republic of Ethiopia Ministry of Health (2010) C1

Download (192)

View PDF (219)

Toolkit for research and development of paediatric antiretroviral drugs and formulations

World Health Organization (WHO); Unitaid; Unicef; et al. World Health Organization (WHO); Unitaid; Unicef; et al. (2018) C_WHO

WHO and UNITAID in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group

Download (732)

View PDF (657)

Disability Inclusive Development Toolkit - CRPD influencing everything we do

Kathy Al Ju’beh Christoffel-Blindenmission (CBM) (2017)

Disability-inclusive development policy and practice is constantly changing and evolving. It is a foundational part of our work in CBM, underpinning all that we do. It requires us to be constantly reflecting, learning and improving our practice. In particular looking to the deeper questions: of the ... more

Download (116)

View PDF (110)

Diabetes and Ramadan: Practical guidelines 2021

Hassanein M., Afandi B. et al. Diabetes Research and Clinical Practice (2016) CC2

The document "Diabetes and Ramadan: Practical Guidelines 2021," published by Elsevier, provides updated guidance for managing diabetes during Ramadan fasting. Developed by the International Diabetes Federation (IDF) and the Diabetes and Ramadan (DAR) International Alliance, the guidelines address ke... more

External Link

European Resuscitation Council Guidelines 2021: Paediatric Life Support

Van de Voorde, P.; et al. European Resuscitation Council (2021) CC

Download (273)

View PDF (277)

Catholic Social Teaching and Social Development in Africa

Centre for Social Justice and Ethics, CUEA (2020) C2

A paper presented during a conference on The Catholic Social Teaching and its Social and Political impact on the Development 9thto 10th December, in Schloss Eichholz Koln/Cologne/GermanyPresented by Sr. Dr. Elizabeth Nduku accessed July 2020